New England Surgical Society (NESS)
Search NESS
  Home
  Annual Meeting
  Annual Resident and Fellow Research Day
  Members
      Member Directory
      Members Only
  Scholars Foundation
  Job Board
  Awards
  Journal of the American College of Surgeons
  Newsletters
  Committees
  Contact NESS

90th Annual Meeting Abstracts


Are Thromboembolic And Bleeding Complications A Drawback For Composite Aortic Root Replacement?
*Emily A Farkas, MD1, *Melody Anderson, BS1, *Ioannis Hatzaras, MD2, John A Elefteriades3
1St. Louis University School of Medicine, St. Louis, MO;2Ohio State University School of Medicine, Columbus, OH, CT;3Yale School of Medicine, New Haven, CT

Objectives: Valve-preserving aortic root reconstruction is being performed with increasing frequency. Independent of durability concerns, enthusiasm for retaining the native valve is often championed against the presumption that traditional composite-graft replacement of the aorta (CGRAo) will be complicated by thromboembolism and bleeding. Because the risk of these complications is highest in the early to mid-term following surgery, this study looks specifically at thromboembolism and bleeding during this timeframe.
Methods: Patients who had CGRAo over a 13-year interval were identified. Follow-up information was obtained by review of perioperative data entered into a prospectively maintained database. Kaplan-Meier disease-free and overall survival analyses were performed.
Results: One-hundred ninety (153 male, 37 female) patients underwent CGRAo between 1995 and 2008. Mean age was 56 years. Indication for surgery was chronic aneurysm in 170, and type A dissection in 20. St. Jude mechanical valve-conduits were used in 164 (86.3%); 26 patients (13.7%) received a biological conduit. Hospital mortality was 3.1% (6/190). Postoperative follow-up ranged from 1-151 months (mean 35.2). Rate of thromboembolism was 1.0% and rate of bleeding was 3.7%. Kaplan-Meier curves showed freedom from bleeding and thromboembolism as 97.7% (CI=95%,SD=3.1) at 60 months, and 95.2% (CI=95%,SD=5.2) at 84 months (FIG-1). Survival was 98.0% (CI=95%,SD=2.60) at 60 months, and 94.1% (CI=95%,SD=5.9) at 84 months.
Conclusions: Few thromboembolism and bleeding complications were experienced after composite-graft replacement of the aorta. These data supporting minimal morbidity with CGRAo in the setting of well-established durability should be used to put alternative procedures, such as valve-preserving aortic root reconstruction, into context.


 

Copyright © 2018 New England Surgical Society. All Rights Reserved.
Read Privacy Policy.